Capital World Investors - REVANCE THERAPEUTICS INC ownership

REVANCE THERAPEUTICS INC's ticker is RVNC and the CUSIP is 761330109. A total of 112 filers reported holding REVANCE THERAPEUTICS INC in Q3 2018. The put-call ratio across all filers is 1.47 and the average weighting 0.7%.

Quarter-by-quarter ownership
Capital World Investors ownership history of REVANCE THERAPEUTICS INC
ValueSharesWeighting
Q3 2023$137,190,605
-43.4%
11,960,820
+24.9%
0.03%
-42.6%
Q2 2023$242,340,061
-25.3%
9,574,874
-5.0%
0.05%
-29.9%
Q1 2023$324,551,213
+85.5%
10,076,101
+6.3%
0.07%
+81.1%
Q4 2022$175,003,680
-19.5%
9,480,156
+17.8%
0.04%
-24.5%
Q3 2022$217,319,000
+242.6%
8,048,838
+75.4%
0.05%
+276.9%
Q2 2022$63,434,000
-2.9%
4,590,000
+37.0%
0.01%
+18.2%
Q1 2022$65,325,000
+7.8%
3,350,000
-9.8%
0.01%
+10.0%
Q4 2021$60,580,000
-26.7%
3,712,000
+25.1%
0.01%
-28.6%
Q3 2021$82,661,000
-6.0%
2,967,0000.0%0.01%
-6.7%
Q2 2021$87,942,000
+22.4%
2,967,000
+15.4%
0.02%
+15.4%
Q1 2021$71,862,000
+19.0%
2,571,102
+20.7%
0.01%
+8.3%
Q4 2020$60,364,000
+12.7%
2,130,0000.0%0.01%0.0%
Q3 2020$53,548,000
+2.9%
2,130,0000.0%0.01%
-7.7%
Q2 2020$52,015,000
+65.0%
2,130,0000.0%0.01%
+44.4%
Q1 2020$31,524,000
-8.8%
2,130,0000.0%0.01%
+12.5%
Q4 2019$34,570,000
+57.8%
2,130,000
+26.4%
0.01%
+60.0%
Q3 2019$21,905,000
+0.2%
1,685,0000.0%0.01%0.0%
Q2 2019$21,854,000
-17.7%
1,685,0000.0%0.01%
-16.7%
Q1 2019$26,556,000
+7.7%
1,685,000
+37.6%
0.01%
-14.3%
Q4 2018$24,659,000
-19.0%
1,225,0000.0%0.01%0.0%
Q3 2018$30,441,000
-22.7%
1,225,000
-14.6%
0.01%
-12.5%
Q2 2018$39,391,0001,435,0000.01%
Other shareholders
REVANCE THERAPEUTICS INC shareholders Q3 2018
NameSharesValueWeighting ↓
NovaQuest Capital Management, L.L.C. 1,558,426$42,779,00061.17%
Essex Woodlands Management, Inc. 3,342,047$91,739,00021.30%
Sio Capital Management, LLC 101,292$2,780,0001.54%
Fosun International Ltd 472,532$12,971,0000.66%
Rhenman & Partners Asset Management AB 203,181$5,577,0000.57%
ArrowMark Colorado Holdings LLC 1,804,275$49,527,0000.46%
ESSEX INVESTMENT MANAGEMENT CO LLC 87,355$2,398,0000.30%
FOX RUN MANAGEMENT, L.L.C. 18,477$507,0000.16%
Phoenix Investment Adviser LLC 2,400$66,0000.12%
Quinn Opportunity Partners LLC 33,100$909,0000.12%
View complete list of REVANCE THERAPEUTICS INC shareholders